multidrug

multidrug

(ˈmʌltɪˌdrʌɡ)
adj
1. (Medicine) involving or relating to the concurrent use of more than one drug
2. (Pathology) resistant to several drugs
References in periodicals archive ?
However, some of the current methods of treatment become ineffective due to multidrug resistance, where cancer cells stop responding to several types of drugs,' he said.
M2 EQUITYBITES-March 7, 2018-Theratechnologies reports US FDA approval for breakthrough multidrug resistant HIV-1 therapy Trogarzo
M2 PHARMA-March 7, 2018-Theratechnologies reports US FDA approval for breakthrough multidrug resistant HIV-1 therapy Trogarzo
Tenders are invited for framework contract for the supply of chemotherapy mats for use inside the clean room, multidrug urine tests and disposable mouth gags.
A prospective study in the Federal States of Micronesia found that of 110 adult and child MDR-TB contacts, administered a tailored (based on the susceptibility pattern of the source case) 12-month, multidrug prophylactic regimen, none developed TB disease.
Extrapulmonary multidrug resistant tuberculosis presenting as chest wall abscess--a rare case report.
However, the emergence of multidrug resistance (MDR), the ability of cancer cells to become simultaneously resistant to different drugs, limits the efficacy of chemotherapy.
has entered an alliance with Cantab Anti-infectives to develop improved antibiotics to treat multidrug resistant Gram-negative bacterial infections.
With data in hand, they were able to create computer models of how multidrug treatments would work.
Objective: Multidrug resistance is a cause of treatment failure in patients with malignant lymphoma; however, the frequency and clinical relevance of multidrug resistance protein expression are unclear.
A growing health concern is the multidrug resistant (MDR) strains of Eshcerichia coli.
Among their topics are using genetically engineered mouse models to study drug resistance in breast cancer, the flow cytometric evaluation of multidrug resistance proteins, drug ration- dependent antagonism as a new category of multidrug resistance and strategies for its circumvention, pharmaco-kinetic and pharmaco-dynamic implications of P-glycoprotein modulation, immuno-suppressors as multidrug resistance reversal agents, and overcoming multidrug resistance by RNA interference.

Full browser ?